IMS Country Review 2016: Philippines

  • ID: 3802074
  • Report
  • Region: Philippines
  • IMS Health
1 of 2
"IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Sales performance is analysed in terms of major corporations, therapeutic classes, major products and new product activity.

Key Benefits:

- Targeted national sales analysis by company, product and therapy areas, allowing you to understand the pharmaceutical performance of the country.
- Synopsis of the healthcare system and relevant pharmaceutical issues, based on primary research gathered by the IMS country experts.
- Standardised comparable data against which the industry is measured, stemming from accurate and reliable IMS audited year-end sales data.

Includes useful measures:
- US$ sales
- 5 year growth in US $ and local currency dollar (eliminating inaccuracies due to exchange rate fluctuations)
- Evolution Index
- market share
- Detailed information file allowing a thorough understanding of the data values and definitions, the universe/country abbreviations, and the EphMRA anatomical therapeutic classification
- Cost-effective strategic analysis tool that will provide the essential insights needed to get insights into a country market of interest
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Note: Product cover images may vary from those shown
Adroll
adroll